327 (Ticlopidine Hydrochloride 250 mg)
Pill with imprint 327 is White, Elliptical/Oval and has been identified as Ticlopidine Hydrochloride 250 mg. It is supplied by Caraco Pharmaceutical Laboratories.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 327
Ticlopidine Hydrochloride
- Imprint
- 327
- Strength
- 250 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Platelet aggregation inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC)
- 57664-0327 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
magnesium silicate,
corn starch,
polyethylene glycol,
hypromelloses,
titanium dioxide,
polysorbate 80,
polyethylene glycol 400
Note: Inactive ingredients may vary.
Related images for "327"
More about ticlopidine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- Compare alternatives
- Drug class: platelet aggregation inhibitors
Patient resources
- Other brands
- Ticlid
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.